Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Treasury Shares (2016 - 2019)

Gyre Therapeutics has reported Treasury Shares over the past 9 years, most recently at $1.6 million for Q4 2019.

  • Quarterly Treasury Shares changed N/A to $1.6 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2019, changed N/A year-over-year, with the annual reading at $1.6 million for FY2019, N/A changed from the prior year.
  • Treasury Shares was $1.6 million for Q4 2019 at Gyre Therapeutics, roughly flat from $1.6 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $1.6 million in Q2 2019 and troughed at $44704.0 in Q1 2017.
  • The 5-year median for Treasury Shares is $1.0 million (2018), against an average of $975708.1.
  • Year-over-year, Treasury Shares crashed 79.89% in 2015 and then soared 2195.98% in 2018.
  • A 5-year view of Treasury Shares shows it stood at $103129.0 in 2015, then soared by 36.71% to $140990.0 in 2016, then soared by 482.84% to $821741.0 in 2017, then surged by 60.53% to $1.3 million in 2018, then increased by 19.59% to $1.6 million in 2019.
  • Per Business Quant, the three most recent readings for GYRE's Treasury Shares are $1.6 million (Q4 2019), $1.6 million (Q3 2019), and $1.6 million (Q2 2019).